Sens. Lamar Alexander (R-TN) and Patty Murray (D-WA) yesterday formally introduced a bill, which has 11 Republican and 11 Democrat cosponsors, intended to stabilize the Health Insurance Marketplaces authorized by the Affordable Care Act. The bill would provide short-term funding for the cost-sharing reductions; expand access to lower-cost, catastrophic health plans; give states additional flexibility to use 1332 waivers; provide states with outreach and education funding; and direct the Department of Health and Human Services to issue regulations facilitating the sale of insurance products across state lines. The bill has not yet been scored by the Congressional Budget Office and would require 60 votes in the Senate to move forward. The AHA and seven other national organizations today thanked Alexander and Murray for their leadership and urged “Congress to take action to enact legislation that includes continued funding for CSR benefits for the rest of 2017 and for at least the next two years (2018-2019).” In addition to AHA, the statement’s signers include America’s Health Insurance Plans, American Academy of Family Physicians, American Benefits Council, American Medical Association, Blue Cross Blue Shield Association, Federation of American Hospitals, and U.S. Chamber of Commerce.

Related News Articles

Headline
The Centers for Disease Control and Prevention Sept. 18 issued a health advisory on a new outbreak of Ebola in the Democratic Republic of the Congo. There are…
Headline
The Centers for Medicare & Medicaid Services Sept. 18 released a final rule on policy and technical changes to Medicare Advantage, the Medicare…
Headline
The Senate Sept. 19 failed to adopt a continuing resolution by a 44-48 vote  that would have funded the government through Nov. 21. The CR was passed by…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Perspective
Public
All of America’s hospitals and health systems, regardless of ownership status, size or location, provide a vast range of benefits, programs and essential…
Headline
The Food and Drug Administration released a final rule Sept. 18 that rescinds one from 2024 that applied medical device rules to laboratory-developed tests.…